GET DAILY SIGNALSCan Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) Reach the $1.00 Level?
Key Takeaways
- The $1.00 level discussed here stems from public conversation and Nasdaq’s minimum bid price rule rather than any broad analyst consensus.
- FRSX recently traded near $0.65, so a move to $1.00 would represent roughly a 54% gain.
- Only one analyst price target appears available at $4.00, well above the current price and not suitable as a near-term benchmark.
- Support could come from the company’s ADAS technology pipeline and partnerships, including work with Tata Elxsi.
- Major risks include ongoing losses, very low revenue, a micro-cap structure, and prior reverse stock splits to stay listed.
- Additional details are available on dedicated pages covering Major News, Today’s Price Move, the Forecast, and Earnings.
Establishing the $1.00 Objective
FRSX lacks a broad analyst consensus. Public records show just one target at $4.00 with a Buy rating, yet that figure sits more than five times higher than the current price and offers little guidance for the near term. MarketBeat does not list a usable consensus. In the absence of reliable aggregate data, the $1.00 mark serves as a practical reference drawn from visible discussion—the psychological round number and Nasdaq’s $1.00 minimum bid price for continued listing. This remains a realistic, publicly referenced milestone above the present level without being overly distant.
Current Position and the Path Forward
At a recent price near $0.65, reaching $1.00 would require an advance of roughly 54%, or about $0.35 in absolute terms. The shares have moved within a $0.61 to $7.00 range over the past year and underwent two reverse splits—a one-for-seven split in August 2025 and a one-for-three split in February 2026—to help satisfy exchange requirements. With a market capitalization in the low millions, the stock remains highly sensitive to news and sentiment shifts. I also checked this using Tickeron’s AI Screener to compare the name against peers in the sector.
Factors That Could Support a Recovery
The company’s core technology stands out as its main strength. Foresight’s QuadSight multi-spectral vision system and Eye-Net Protect cellular V2X solution address expanding ADAS and autonomous-driving markets. A prior collaboration with Tata Elxsi on stereo-vision ADAS for the Indian market offers one example of potential commercial traction. Fresh contracts, revenue-generating partnerships, or licensing deals could help re-rate a name that currently generates minimal revenue. Broader interest in small-cap automotive technology names might also lend support toward the $1.00 level.
Obstacles That Could Limit Progress
Balance-sheet and operating realities present the clearest hurdles. FRSX has produced only modest trailing revenue in the low hundreds of thousands while recording persistent net losses and negative EPS. Ongoing cash consumption raises the possibility of further financing that could dilute shareholders. The history of reverse splits underscores the challenge of maintaining a compliant bid price, and a stock that has declined sharply from its 52-week high faces both technical and psychological resistance on any rebound. Competition from larger ADAS suppliers adds another layer of uncertainty for this micro-cap ADR.
Technical Levels and Market Structure
The $0.61 area near the 52-week low represents a notable support zone, while $1.00 functions as both a psychological round number and a regulatory threshold under Nasdaq rules. Any advance would first need to exit the sub-dollar range, and the wide distance to the 52-week high near $7.00 highlights how far sentiment has shifted. Low trading volume and a small float can amplify price moves in either direction. From what I see, monitoring volume alongside these levels remains useful.
Time Horizon and Items to Watch
Analyst targets generally reflect a roughly 12-month outlook, yet the single available figure for FRSX leaves no dependable timeline. Investors should track upcoming earnings and any guidance, announcements of new partnerships or contracts, cash position and financing moves, and any further steps related to Nasdaq listing compliance. Updates to the lone published target, if coverage expands, would also matter.
Reviewing AI Daily Buy/Sell Signals
I have found Tickeron’s AI Daily Buy/Sell Signals helpful for following momentum in names like this. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market conditions. For a thinly traded micro-cap, these signals can surface shifts in sentiment without constant manual monitoring, allowing traders to complement their own research efficiently.
Final Assessment
Whether FRSX can reach $1.00 depends on roughly a 54% recovery from current levels, and that target reflects a publicly discussed regulatory and psychological milestone rather than analyst consensus. The ADAS and vision technology along with existing partnerships represent genuine sources of potential upside, yet persistent losses, minimal revenue, cash burn, and prior reverse splits weigh on the outlook. With essentially one far-above-market target available, independent price validation remains limited. Focus on new commercial agreements, funding developments, and listing-related actions while recognizing that a move to $1.00 is possible but far from certain.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
FRSX's Stochastic Oscillator is staying in oversold zone for 7 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
Following a +3.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where FRSX advanced for three days, in 148 of 193 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
FRSX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FRSX as a result. In 75 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for FRSX turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 42 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FRSX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for FRSX entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.376) is normal, around the industry mean (0.773). P/E Ratio (-0.095) is within average values for comparable stocks, (40.481). Projected Growth (PEG Ratio) (0.620) is also within normal values, averaging (1.494). Dividend Yield (0.046) settles around the average of (0.042) among similar stocks. P/S Ratio (9.643) is also within normal values, averaging (49.456).
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. FRSX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FRSX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of residential and commercial real estate properties
Industry AutoPartsOEM
Advertisement